These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 7907097

  • 21. Effects of treatment with etizolam 0.5 mg BID on cognitive performance: a 3-week, multicenter, randomized, double-blind, placebo-controlled, two-treatment, three-period, noninferiority crossover study in patients with anxiety disorder.
    De Candia MP, Di Sciascio G, Durbano F, Mencacci C, Rubiera M, Aguglia E, Garavini A, Bersani G, Di Sotto A, Placidi G, Cesana BM.
    Clin Ther; 2009 Dec; 31(12):2851-9. PubMed ID: 20110024
    [Abstract] [Full Text] [Related]

  • 22. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial.
    Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J.
    Depress Anxiety; 2008 Dec; 25(3):182-9. PubMed ID: 17311303
    [Abstract] [Full Text] [Related]

  • 23. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB, Ballenger JC, Rickels K.
    J Clin Psychiatry; 1997 Dec; 58 Suppl 11():11-8. PubMed ID: 9363043
    [Abstract] [Full Text] [Related]

  • 24. A comparative study of alpidem, a nonbenzodiazepine, and lorazepam in patients with nonpsychotic anxiety.
    Diamond BI, Nguyen H, O'Neal E, Ochs R, Kaffeman M, Borison RL.
    Psychopharmacol Bull; 1991 Dec; 27(1):67-71. PubMed ID: 1677774
    [Abstract] [Full Text] [Related]

  • 25. Antianxiety effects of lorazepam in patients with cardiovascular symptomatology.
    Finkel S.
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):35-40. PubMed ID: 30766
    [Abstract] [Full Text] [Related]

  • 26. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 27. Multicenter, randomized, double-blind, active comparator and placebo-controlled trial of a corticotropin-releasing factor receptor-1 antagonist in generalized anxiety disorder.
    Coric V, Feldman HH, Oren DA, Shekhar A, Pultz J, Dockens RC, Wu X, Gentile KA, Huang SP, Emison E, Delmonte T, D'Souza BB, Zimbroff DL, Grebb JA, Goddard AW, Stock EG.
    Depress Anxiety; 2010 May; 27(5):417-25. PubMed ID: 20455246
    [Abstract] [Full Text] [Related]

  • 28. Comparative efficacy of propranolol, chlordiazepoxide, and placebo in the treatment of anxiety: a double-blind trial.
    Meibach RC, Dunner D, Wilson LG, Ishiki D, Dager SR.
    J Clin Psychiatry; 1987 Sep; 48(9):355-8. PubMed ID: 3305488
    [Abstract] [Full Text] [Related]

  • 29. Ziprasidone treatment of refractory generalized anxiety disorder: a placebo-controlled, double-blind study.
    Lohoff FW, Etemad B, Mandos LA, Gallop R, Rickels K.
    J Clin Psychopharmacol; 2010 Apr; 30(2):185-9. PubMed ID: 20520293
    [Abstract] [Full Text] [Related]

  • 30. Randomized, placebo-controlled trial of risperidone for acute treatment of bipolar anxiety.
    Sheehan DV, McElroy SL, Harnett-Sheehan K, Keck PE, Janavs J, Rogers J, Gonzalez R, Shivakumar G, Suppes T.
    J Affect Disord; 2009 Jun; 115(3):376-85. PubMed ID: 19042026
    [Abstract] [Full Text] [Related]

  • 31. Kava-kava extract WS 1490 versus placebo in anxiety disorders--a randomized placebo-controlled 25-week outpatient trial.
    Volz HP, Kieser M.
    Pharmacopsychiatry; 1997 Jan; 30(1):1-5. PubMed ID: 9065962
    [Abstract] [Full Text] [Related]

  • 32. Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
    Rickels K, Pollack MH, Feltner DE, Lydiard RB, Zimbroff DL, Bielski RJ, Tobias K, Brock JD, Zornberg GL, Pande AC.
    Arch Gen Psychiatry; 2005 Sep; 62(9):1022-30. PubMed ID: 16143734
    [Abstract] [Full Text] [Related]

  • 33. Buspirone: multicenter efficacy study.
    Wheatley D.
    J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):92-4. PubMed ID: 6130079
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms.
    Sramek JJ, Tansman M, Suri A, Hornig-Rohan M, Amsterdam JD, Stahl SM, Weisler RH, Cutler NR.
    J Clin Psychiatry; 1996 Jul; 57(7):287-91. PubMed ID: 8666569
    [Abstract] [Full Text] [Related]

  • 35. [Modification of cognitive functions by 2 anxiolytic treatments in patients suffering from generalized anxiety].
    Samuelian JC, Billardon M, Guillou N.
    Encephale; 1995 Jul; 21(2):147-53. PubMed ID: 7781586
    [Abstract] [Full Text] [Related]

  • 36. Effect of clorazepate on depressed mood in anxious patients.
    Zung WW.
    J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
    [Abstract] [Full Text] [Related]

  • 37. An evaluation of the anxiolytic SC 48,274 in generalized anxiety disorder (GAD).
    Cutler NR, Sramek JJ, Macpherson AE, Doss MG, Benes CO, Howard SF.
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Jul; 18(4):685-94. PubMed ID: 7938559
    [Abstract] [Full Text] [Related]

  • 38. A double-blind, controlled trial in primary care patients with generalized anxiety: a comparison between buspirone and oxazepam.
    Strand M, Hetta J, Rosen A, Sörensen S, Malmström R, Fabian C, Marits K, Vetterskog K, Liljestrand AG, Hegen C.
    J Clin Psychiatry; 1990 Sep; 51 Suppl():40-5. PubMed ID: 2211567
    [Abstract] [Full Text] [Related]

  • 39. Therapeutic effectiveness of Galphimia glauca vs. lorazepam in generalized anxiety disorder. A controlled 15-week clinical trial.
    Herrera-Arellano A, Jiménez-Ferrer JE, Zamilpa A, García-Alonso G, Herrera-Alvarez S, Tortoriello J.
    Planta Med; 2012 Sep; 78(14):1529-35. PubMed ID: 22828921
    [Abstract] [Full Text] [Related]

  • 40. Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.
    Bose A, Korotzer A, Gommoll C, Li D.
    Depress Anxiety; 2008 Sep; 25(10):854-61. PubMed ID: 18050245
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.